And nowhere else will this issue be as prominent as in Miami-Dade. The county had the highest rate of HIV transmission among ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

The Rwanda Biomedical Center (RBC) said last week that the government plans to introduce lenacapavir, a long-acting ...

For most of its history, the US military has refused to recruit HIV-positive soldiers. The Trump administration appears to be ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, McGill University researchers report. A new study published ...

An AIDS drug already shown to help prevent spread of the virus in gay men also works for heterosexual men and women, two studies in Africa found.

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

Prescription medication is a lifeline for millions of people around the U.S. Unfortunately, the cost of such medications has ...